US2018296626A1PendingUtilityA1

Medicinal composition for prevention or treatment retinal ischemia

49
Assignee: CHAO HSIAO MINGPriority: Apr 18, 2017Filed: Nov 13, 2017Published: Oct 18, 2018
Est. expiryApr 18, 2037(~10.7 yrs left)· nominal 20-yr term from priority
Inventors:Hsiao-Ming Chao
A61K 36/736A61K 36/21A61K 36/752A61K 36/23A61K 36/232A61K 36/64A61K 36/484A61K 36/286A61K 36/65A61K 36/346A61K 36/233
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to a method of preventing or treating a disease, disorder or condition induced by retina ischemia comprising administrating a subject a therapeutically effective amount of a RBP2 inhibitor for preventing or treating a disease, disorder or condition induced by retina ischemia.

Claims

exact text as granted — not AI-modified
1 . A method of preventing or treating a disease, disorder or condition induced by retina ischemia comprising administrating a subject a therapeutically effective amount of a RBP2 inhibitor for preventing or treating a disease, disorder or condition induced by retina ischemia. 
     
     
         2 . The method according to  claim 1 , wherein the RBP2 inhibitor is Xue-Fu-Zhu-Yu decoction.

Join the waitlist — get patent alerts

Track US2018296626A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.